| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±10.8% | +0.6% | over-priced |
| 05/01/2026 | ±3.1% | -2.5% | over-priced |
| 10/31/2025 | ±5.3% | -0.6% | over-priced |
| 08/01/2025 | ±4.9% | -1.3% | over-priced |
| 05/02/2025 | ±3.2% | +0.6% | over-priced |
| 08/02/2024 | ±4.6% | -3.5% | over-priced |
| 05/03/2024 | ±4.8% | +0.3% | over-priced |
| 11/03/2023 | ±2.6% | +0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.56 | $4.9B | $187M |
| Q1 FY2026 | $1.22 | $4.0B | $147M |
| Q4 FY2025 | $1.12 | $3.9B | $136M |
| Q3 FY2025 | $1.34 | $4.1B | $163M |
C.H. Robinson Worldwide, Inc. (CHRW) reports in 75 days, with the next report estimated for 11/21/2026. Across the last 8 reports, options priced an average ±4.9% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced CHRW's earnings risk. Fundamentals into the print: EPS up 23.8% year-over-year, revenue up 19.3%. QuantLogix's live 5-factor engine currently reads CHRW as a neutral at 44/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →